Schedule 13G ownership disclosure

OKYO PHARMA LTD

Common · CUSIP: G6724L116

Event date: 2025-09-30

Filing-level shares
2,422,048.00
Percent of class
6.3%
  • Dauntless Investment Group, LLC

    Shares: 2,422,048.00 · Class: 6.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002044285-25-000014
Form type
SCHEDULE 13G/A
Filer
Dauntless Investment Group, LLC
CIK
CIK 2044285
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub